News
A New Tool for Healthcare Gives Better Outbreak Forecasts
Pinpointing an outbreak’s peak, the approach can boost health systems’ preparedness and risk communication.
New Gene-Editing Tech Holds Promise for Treating Complex Genetic Diseases
Advanced biotechnology repurposes two bacterial immune systems to correct large stretches of DNA.
High-Resolution Structure Reveals How Microcins Target Bacteria
The Davies Lab and NIH researchers reveal the first high-resolution structure of a microcin binding its bacterial receptor.
Virus Slayer Awarded ‘Genius Grant’ by MacArthur Foundation
The award recognizes Jason McLellan’s work to investigate how viruses infect our cells and to develop new treatments for infectious disease.
In Memoriam: Emin Ulug
Emin Ulug, retired Molecular Biosciences Associate Professor of Instruction passed away on September 12 after a long illness.
Re-engineered Antibodies Kill Bacteria Directly
These antibodies use a clever trick to slip deep into a bacteria’s outer membrane, where they can do real damage.
Davies Lab Research Finds Wide Diversity of Microcins
The study, recently published in Nature Communications, could lead to new ways to treat antibiotic-resistant infections.
LCID Researcher's Work to Translate Science Featured on UNESCO Website
Dr. Grace Kago's science e-learning community for native Kikuyu speakers is chosen for UNESCO's Open and Inclusive Science Hub.
Julie Gerberding Discusses Precision Health at 2025 LaMontagne Symposium Keynote Lecture
The title of Dr. Gerberding's lecture was "Beyond One-Size-Fits-All: Rebuilding Trust and Advancing Precision Public Health in the AI Era"
Maynard, McLellan Labs Study Boosting Pertussis Vaccines
Researchers in the labs of LCID members Jennifer Maynard and Jason McLellan have made discoveries in understanding and enhancing immunity against pertussis.
